MeSH tree: G05.360.080
Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate ...
Sep 12, 2024
0
40
Using a novel stem cell platform, a team of MUSC researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated ...
Sep 10, 2024
0
38
"Parasite" DNA sequences have three potential functions in the development of T (for thymus) lymphocytes, researchers led by Université de Montréal medical professor Claude Perreault show in a study published in the journal ...
Sep 4, 2024
0
59
Researchers at the University of Kentucky are testing the effectiveness of a vaccine that may be able to treat pancreatic cancer.
Sep 4, 2024
0
53
Rare genetic changes that are spontaneous—and not inherited from parents—may contribute to the underpinnings of attention-deficit/hyperactivity disorder (ADHD), according to a new study from Yale School of Medicine.
Aug 13, 2024
0
102
Scientists at St. Jude Children's Research Hospital have created a panel that is able to provide a diagnosis for more than 90% of pediatric cancer patients by sequencing 0.15% of the human genome. The panel is a cost-effective ...
Aug 2, 2024
0
46
Researchers at the Leibniz Institute for Immunotherapy (LIT) describe a new type of regulation of immune cells by so-called "jumping genes."
Jul 23, 2024
0
112
Tuberculosis dates back more than 9,000 years. It is the most infectious bacterial disease, and in 2022 10.6 million people fell ill with it. Of these cases, 23% occurred in Africa.
Jul 22, 2024
0
22
Addressing problems with diagnosing and treating breast cancer, scientists at EPFL have developed EMBER, a tool that integrates breast cancer transcriptomic data from multiple databases. EMBER can improve precision oncology ...
Jul 19, 2024
0
94
A study led by researchers at Brighton and Sussex Medical School (BSMS) has unveiled an approach to predicting the effectiveness of treatments for patients with diffuse large B-cell lymphoma (DLBCL), a common form of blood ...
Jul 15, 2024
0
35
